Skip to main content
. Author manuscript; available in PMC: 2024 Jan 17.
Published in final edited form as: Drug Dev Res. 1996 Nov-Dec;39(3-4):253–261. doi: 10.1002/(sici)1098-2299(199611/12)39:3/4<253::aid-ddr4>3.0.co;2-q

Figure 4.

Figure 4.

Competitive antagonist activity of adenosine 3′-phosphate 5′-phosphosulfate. Turkey erythrocyte membranes were incubated in the presence of the indicated concentrations of adenosine 3′-phosphate 5′-phosphosulfate and no additional drug (open circles), 10 nM 2MeSATP (filled circles), or 100 nM 2MeSATP (open squares). Inositol phosphate accumulation was measured as a quantitation of PLC activity.